SLFN5 inhibits the motility and invasiveness of malignant renal cell carcinoma cells by negatively controlling the expression of matrix metalloproteinase genes (such as MMP-1 and MMP-13). The gene discussed is SLFN5; the disease is hereditary clear cell renal cell carcinoma.